BN Business News
Add your company to Business Communicator →

Regulation & law · 31/01/2022Updated: 10/17/2026 · 1 min read

Federal Judge Approves Pfizer's Acquisition of Mylan Pharmaceuticals, Rejects Erythropoietin Biosimilar Proposal

Summary

U.S. District Judge Bradley H. Chesler has approved Pfizer's acquisition of Mylan Pharmaceuticals, rejecting a proposal for a biosimilar version of Mylan's erythropoietin product, which is used to treat anemia in patients with chronic kidney disease.

Original source language: Federal Register — Justice DepartmentOpen original release →

Explore insights

Business insights →